Willeke Danckaert

Add to list

Nontarget dose accuracy and reliability of a treatment planning system during prostate radiotherapy

Willeke Danckaert (UGent) , Piet Ost (UGent) and Carlos De Wagter (UGent)

(2023) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 182(Supplement 1). p.S1776-S1777

Add to list

PhD Thesis

Detection of biomarkers to reduce radiation-induced toxicities and improve clinical outcomes, with emphasis on the role of unintended dose

Willeke Danckaert (UGent)

(2023)

Add to list

Microbiome and metabolome dynamics during radiotherapy for prostate cancer

Willeke Danckaert (UGent) , Mathieu Spaas (UGent) , Nora Sundahl, Aurélie De Bruycker, Valerie Fonteyne (UGent) , Ellen De Paepe (UGent) , Carlos De Wagter (UGent) , Lynn Vanhaecke (UGent) and Piet Ost (UGent)

(2023) RADIOTHERAPY AND ONCOLOGY. 189.

Add to list

Journal Article
A1
open access

Dosimetric and hematologic implications of prostate-only versus whole pelvic radiotherapy : results of the multicentric phase 3 PROPER study

Valerie Fonteyne (UGent) , Willeke Danckaert (UGent) , Piet Ost (UGent) , Charlien Berghen, Katrien Vandecasteele (UGent) , Ben Vanneste (UGent) , Kato Rans, Nick Liefhooghe, Steven Wallaert (UGent) and Leen Paelinck (UGent)

(2023) TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 22.

Add to list

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu Spaas (UGent) , Nora Sundahl, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2023) JAMA ONCOLOGY. 9(9). p.1205-1213

Add to list

Journal Article
A1
open access

Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy

Willeke Danckaert (UGent) , Piet Ost (UGent) and Carlos De Wagter (UGent)

(2023) JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS. 24(8).

Add to list

Journal Article
A1
open access

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Willeke Danckaert (UGent) , Mathieu Spaas (UGent) , Katrien Vandecasteele (UGent) , Carlos De Wagter (UGent) and Piet Ost (UGent)

(2022) RADIOTHERAPY AND ONCOLOGY. 170. p.64-69

Academic Bibliography

Willeke Danckaert

Nontarget dose accuracy and reliability of a treatment planning system during prostate radiotherapy

Detection of biomarkers to reduce radiation-induced toxicities and improve clinical outcomes, with emphasis on the role of unintended dose

Microbiome and metabolome dynamics during radiotherapy for prostate cancer

Dosimetric and hematologic implications of prostate-only versus whole pelvic radiotherapy : results of the multicentric phase 3 PROPER study

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Contents

Support

Contact